EffCaMgCit for PPI Complications

Withdrawn Phase 3 NCT05998863

Study Description

A Study of Effervescent Calcium Magnesium Citrate to Prevent Mineral Metabolism and Kidney Complications from Long-Term Use of Proton Pump Inhibitors

Study Details

Registry ID:
NCT05998863
Conditions:
Osteoporosis, Hypomagnesemia
Phase:
Phase 3
Start Date:
Age Range:
21–99 years
Healthy Volunteers:
No

Study Locations (2 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →